Damir Vrbanec

Damir Vrbanec

University of Pula - Pula / Croatia
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1579596
Juraj Dobrila University of Pula
person_outline Damir Vrbanec's MOST POPULAR ARTICLES
1-) Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 … The Lancet Oncology 21 (4), 519-530, 2020
2-) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial The lancet oncology 18 (12), 1688-1700, 2017
3-) Delays in diagnosis and treatment of breast cancer: a multinational analysis The European journal of public health 24 (5), 761-767, 2014
4-) Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial World journal of gastroenterology: WJG 16 (25), 3133, 2010
5-) Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors World journal of gastroenterology: WJG 19 (4), 523, 2013